Metasphere Labs Inc (LABZ.NE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Cboe CA]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
(Values in thousands)
| 07-2025 | 07-2024 | 07-2023 | 07-2022 | 07-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 0 | 112 | 403 | 238 | N/A |
| Accounts receivable | 42 | 9 | 105 | -215 | N/A |
| Accounts payable and accrued liabilities | -568 | 66 | 493 | 765 | N/A |
| Other Working Capital | -537 | -1,682 | 490 | 10 | 40 |
| Other Operating Activity | -148 | 498 | -3,547 | -1,445 | -53 |
| Operating Cash Flow | $-1,212 | $-997 | $-2,057 | $-646 | $-12 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 0 | -413 | N/A |
| Net Acquisitions | N/A | 0 | 804 | 226 | N/A |
| Purchase Sale Intangibles | N/A | 0 | -451 | -1,848 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -851 | 0 |
| Investing Cash Flow | $N/A | $0 | $353 | $-2,886 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -86 | -176 | 1,250 | -65 | N/A |
| Debt Repayment | N/A | 0 | -113 | -129 | N/A |
| Common Stock Issued | 0 | 1,001 | 0 | 3,994 | N/A |
| Other Financing Activity | 455 | 1,025 | 347 | 60 | 0 |
| Financing Cash Flow | $369 | $1,850 | $1,484 | $3,860 | $N/A |
| Exchange Rate Effect | N/A | 0 | -41 | -22 | N/A |
| Beginning Cash Position | 900 | 47 | 308 | 2 | 15 |
| End Cash Position | 57 | 900 | 47 | 308 | 2 |
| Net Cash Flow | $-843 | $853 | $-220 | $328 | $-12 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,212 | -997 | -2,057 | -646 | -12 |
| Capital Expenditure | N/A | N/A | -451 | -2,354 | N/A |
| Free Cash Flow | -1,212 | -997 | -2,508 | -3,000 | -12 |